(Q46896407)

26 December 2017

title

Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer's disease (English)

1 reference

26 December 2017

0 references

Debby Van Dam

1

1 reference

26 December 2017

Katrien Coen

series ordinal

2

1 reference

26 December 2017

Peter Paul De Deyn

series ordinal

3

1 reference

26 December 2017

publication date

16 November 2007

1 reference

26 December 2017

published in

Psychopharmacology

1 reference

26 December 2017

volume

197

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

37-43

1 reference

26 December 2017

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-007-1010-X

Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s Disease

21 January 2018

1 reference

12 December 2020

Acetylcholinesterase inhibitors as a starting point towards improved Alzheimer's disease therapeutics

1 reference

12 December 2020

Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors

1 reference

12 December 2020

Cholinergic receptor interactions and their effects on long-term memory processing.

1 reference

12 December 2020

Drug discovery in dementia: the role of rodent models

1 reference

12 December 2020

Progressive age-related impairment of cognitive behavior in APP23 transgenic mice

1 reference

12 December 2020

Galantamine and donepezil attenuate pharmacologically induced deficits in prepulse inhibition in rats

1 reference

12 December 2020

Effect of YM796, a novel muscarinic agonist, on the impairment of passive avoidance response in senescence-accelerated mice

1 reference

12 December 2020

Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade

1 reference

12 December 2020

Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment of Alzheimer's disease

1 reference

12 December 2020

Modulation of N-methyl-D-aspartate receptors by donepezil in rat cortical neurons

1 reference

12 December 2020

Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model.

1 reference

12 December 2020

On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis

1 reference

12 December 2020

Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine

1 reference

12 December 2020

The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor

1 reference

12 December 2020

Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors

1 reference

12 December 2020

Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors

1 reference

12 December 2020

Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group.

1 reference

12 December 2020

Aggressive male APP23 mice modeling behavioral alterations in dementia

1 reference

12 December 2020

Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances

1 reference

12 December 2020

Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study

1 reference

12 December 2020

Comparison of the effects of cholinesterase inhibitors on [3H]MK-801 binding in rat cerebral cortex

1 reference

12 December 2020

Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid

1 reference

12 December 2020

Do cholinesterase inhibitors have disease-modifying effects in Alzheimer's disease?

1 reference

12 December 2020

σ-1 Receptors (σ1Binding Sites) Form Raft-Like Microdomains and Target Lipid Droplets on the Endoplasmic Reticulum: Roles in Endoplasmic Reticulum Lipid Compartmentalization and Export

1 reference

12 December 2020

Age-dependent cognitive decline in the APP23 model precedes amyloid deposition

1 reference

12 December 2020

The behavioral effects of heptylphysostigmine on rats lesioned in the nucleus basalis

1 reference

12 December 2020

beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies

1 reference

12 December 2020

Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model

1 reference

12 December 2020

What constitutes clinical evidence for neuroprotection in Alzheimer disease: support for the cholinesterase inhibitors?

1 reference

12 December 2020

Pathogenic mechanisms of Alzheimer's disease analyzed in the APP23 transgenic mouse model

1 reference

12 December 2020

Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation

1 reference

12 December 2020

An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors.

1 reference

12 December 2020

Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models

1 reference

12 December 2020

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

1 reference

12 December 2020

Acetylcholinesterase-amyloid-beta-peptide interaction and Wnt signaling involvement in Abeta neurotoxicity

1 reference

12 December 2020

Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease

1 reference

12 December 2020

Effect of rivastigmine on scopolamine-induced memory impairment in rats.

1 reference

12 December 2020

Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?

1 reference

12 December 2020

Donepezil for dementia due to Alzheimer's disease

1 reference

12 December 2020

Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration

1 reference

12 December 2020

Dimeric and hybrid anti-Alzheimer drug candidates

1 reference

12 December 2020

Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies.

1 reference

12 December 2020

TAK-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons

1 reference

12 December 2020

10.1007/S00213-007-1010-X

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017